Assessing the comparative effectiveness of long-acting injectable vs. oral antipsychotic medications in the prevention of relapse provides a case study in comparative effectiveness research in psychiatry
about
Impact of long-acting injectable antipsychotics on medication adherence and clinical, functional, and economic outcomes of schizophreniaCritical appraisal of 3-monthly paliperidone depot injections in the treatment of schizophreniaEfficacy and tolerability of aripiprazole once monthly for schizophrenia: a systematic review and meta-analysis of randomized controlled trialsLong-acting injectable versus daily oral antipsychotic treatment trials in schizophrenia: pragmatic versus explanatory study designsCurrent and emergent treatments for symptoms and neurocognitive impairment in schizophrenia.Treatment continuation of four long-acting antipsychotic medications in the Netherlands and Belgium: A retrospective database studyThe role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal.Efficacy and safety of flexibly dosed paliperidone palmitate in Chinese patients with acute schizophrenia: an open-label, single-arm, prospective, interventional study.Functional MRI Evaluation of Multiple Neural Networks Underlying Auditory Verbal Hallucinations in Schizophrenia Spectrum Disorders.Factors Associated with Adherence to the HEDIS Quality Measure in Medicaid Patients with Schizophrenia.Switching away from pipotiazine palmitate: a naturalistic study.Antipsychotic prescribing of consultant forensic psychiatrists working in different levels of secure care with patients with schizophrenia.Treatment resistance and other complicating factors in the management of schizophrenia.Glutamatergic agents for schizophrenia: current evidence and perspectives.Determinants of adherence to treatment in first-episode psychosis: a comprehensive review.The Use of Continuous Treatment Versus Placebo or Intermittent Treatment Strategies in Stabilized Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with First- and Second-Generation Antipsychotics.Clinical benefits and impact of early use of long-acting injectable antipsychotics for schizophrenia.A further consideration on long-acting injectable versus oral antipsychotics in the treatment of schizophrenia: a narrative review and critical appraisal.Emerging Role of MicroRNAs as Liquid Biopsy Biomarkers in Gastrointestinal Cancers.Benefit-risk assessment of paliperidone oral extended-release tablet versus monthly injectable for maintenance treatment of schizophrenia.Risk of discontinuation of antipsychotic long-acting injections vs. oral antipsychotics in real-life prescribing practice: a community-based study.Comparison and predictors of treatment adherence and remission among patients with schizophrenia treated with paliperidone palmitate or atypical oral antipsychotics in community behavioral health organizations.Long-acting injectable antipsychotics for prevention and management of violent behaviour in psychotic patients.Efficacy of Jian'ganle () versus Hugan Pian (), glucuronolactone and reduced glutathione in prevention of antituberculosis drug-induced liver injury.Comparative effectiveness of injectable paliperidone palmitate versus oral atypical antipsychotics: early postmarketing evidence."Impact of drug-reimbursement policies on prescribing: A case-study of a newly marketed long-acting injectable antipsychotic among relapsed schizophrenia patients".Notes on the use of randomised controlled trials to evaluate complex interventions: Community treatment orders as an illustrative case.What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia?Identifying patients and clinical scenarios for use of long-acting injectable antipsychotics - expert consensus survey part 1.Initiating/maintaining long-acting injectable antipsychotics in schizophrenia/schizoaffective or bipolar disorder - expert consensus survey part 2.
P2860
Q24597701-84C9E11C-DCD6-49A6-BF14-2BC19543DD31Q26745792-A651D214-078B-4331-A69C-844402D512F7Q26781173-64FFCD9D-8850-4C85-914E-D1C4AE0F54C3Q28085407-933B9CFB-1313-43A8-B1D8-7C13975506D2Q30382281-BE5CAC58-E888-477B-9811-8909193EC590Q33797431-965B4CBE-F118-44C5-8E30-4CC4BA62387AQ34418847-075F1A0C-8A42-4C57-978E-7AA1473E8D76Q35794615-827CEF65-BE8F-472B-B65F-6BEB04B7680EQ36735317-8A8F3ABC-68D5-4664-9DD5-CC0BA376D989Q37441407-62761E1F-28B0-4BE1-8A6D-C6A1E01D441AQ37582712-E06AAC5A-A954-475B-9B6D-644EB3C813E9Q37733957-25103A78-C252-4AB1-973C-35D0433D4AABQ38269768-96F787D5-7F1B-4D21-AAF9-54249FD1DE1EQ38444551-0E5F2267-6C47-4089-88A5-FE98E5011652Q38462271-6992EAD3-4946-49D5-B385-CD8159937C78Q38570636-E17D5176-3E74-4BE4-9DB5-27B58C5C17CCQ38592404-96290A63-C430-4E9F-8C20-9B10989123BAQ38659006-C537F5FE-0735-40FD-A26E-807D20170D0AQ38763590-FFB2B437-A370-4BA0-8D2F-C6DE7701DE58Q39585148-0C39216E-D7F7-4947-A372-1773A8B422B2Q40278766-32E657A8-BEEA-4B1F-B1D4-BE31C90A4F92Q42659528-AF4499D6-D978-4DFB-AE0B-3ED376B97B27Q42687636-689000D3-AA15-4B58-B0B5-51E7E0574689Q44040450-3D3D6322-A3CA-40D6-9AAF-7908DC9740DDQ45895632-1F3E8DA7-1F53-4205-B6A8-8132457FB888Q47424833-494F4025-F59C-4990-9901-92F382BE48F5Q52753334-9883D537-0249-4831-AE15-9EDE6E7C3185Q55023835-20F5935D-A8C8-468C-BAB7-2EB5BBA68B47Q55364906-837A9D99-3876-4C1A-8F6D-FBE6C4A1867AQ55438360-5D7FBBAC-8A29-4295-BF73-11D7930FDD4D
P2860
Assessing the comparative effectiveness of long-acting injectable vs. oral antipsychotic medications in the prevention of relapse provides a case study in comparative effectiveness research in psychiatry
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Assessing the comparative effe ...... iveness research in psychiatry
@ast
Assessing the comparative effe ...... iveness research in psychiatry
@en
Assessing the comparative effe ...... iveness research in psychiatry
@nl
type
label
Assessing the comparative effe ...... iveness research in psychiatry
@ast
Assessing the comparative effe ...... iveness research in psychiatry
@en
Assessing the comparative effe ...... iveness research in psychiatry
@nl
prefLabel
Assessing the comparative effe ...... iveness research in psychiatry
@ast
Assessing the comparative effe ...... iveness research in psychiatry
@en
Assessing the comparative effe ...... iveness research in psychiatry
@nl
P2860
P1476
Assessing the comparative effe ...... iveness research in psychiatry
@en
P2093
Christoph U Correll
Taishiro Kishimoto
P2860
P304
P356
10.1016/J.JCLINEPI.2013.01.012
P433
P50
P577
2013-08-01T00:00:00Z